IMHRS Meeting: Posters I June 17-19, 2004


Poster sessions
Alopecia Areata
P7.71 Observations on the external application of microelements in alopecia areata treatment
W. Garncarz. Wroclaw, Poland.
P7.72 The progressive alopecia areata disease state and therapeutic response towards a contact sensitizer are reflected in peripheral blood mononuclear cells
K. J. McElwee, P. Freyschmidt-Paul, M. Zцller, M. Vitacolonna and R. Hoffmann. Marburg and Heidelberg, Germany.
P7.73 Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients
K. J. McElwee, P. Freyschmidt-Paul, M. Zцller and R. Hoffmann. Marburg, Freiburg and Heidelberg, Germany.
P7.74 Alopecia areata: do these subjects have common personality traits?
R. d’Ovidio, J. Claudatus and T. Di Prima. Catania, Italy.
P7.75 Clinical significance of the HLA-DR11 positive subset in patients with alopecia areata
C. Marques Da Costa, J.J. Stene, E. Dupont, M. Vandercruys, M. Hidajat and M. Andrien. Bruxelles, Belgium.
P7.76 Alopecia areata : topical treatment with anthralin (cignolin)
G. Staib and K. Scharfetter-Kochanek. Ulm, Germany.
P7.77 Children with alopecia areata – analysis of the Cleveland Clinic Foundation experience
W. F. Bergfeld, N. C. Dombrowski, B. K. Remzi and J. M. Leonhardt. Cleveland, USA.
P7.78 Alopecia areata in eyebrows treated with superficial cryotherapy: case reports
Soo Young Jeon, Bong Kyun Ahn, Sanghoon Lee and Won-Soo Lee. Wonju, Korea.
P7.79 Correlation between disease duration and the effect of methylprednisolone pulse therapy for alopecia areata
J. K. Park, M. Im, M. S. Park, Y. J. Seo and J. H. Lee. Teajon, Korea.
P7.80 The optimal dose of topical diphenylcylopropenone sensitization for the treatment of alopecia areata: preliminary study
M. Im, Y. Joon Seo, J. H. Lee and J. K. Park. Teajon, Korea.
P7.81 Adult onset alopecia areata is a complex polygenic trait in the C3H/HEJ mouse
J. P. Sundberg, K. Silva, R. Li, G.A. Cox and L. E. King. Bar Harbor and Nashville, USA.
P7.82 Phylogenetic tissue arrays for comparison of alopecia areata between species
J. P. Sundberg, J. Miller, K. McElwee, T. Olivry, R. D., T. L. Gross, S. Whitehead, D. Whiting, M. Hogan and L. E. King. Bar Harbor, Marburg, Raleigh, Texas, West Sacramento, Nashville, Dallas and San Diego, Germany and USA.
P7.83 A TH1 - associated anti-hair follicle IgG1 antibody response predominates in human alopecia areata
M. L. O’Shea, L. Mooney, J.-C. Bystryn and D. J. Tobin. Bradford and New York, UK and USA.
P7.84 Alopecia areata of children in Korea (1991-2003)
J. Y. Ahn, J. E. Kim and B. I. Ro. Seoul, Korea.
P7.85 Clinical evaluation of linear polarized infrared irradiation using super lizertm for chronic stable alopecia areata patients
U. Rie, M. Mio and O. Hedeoki. Tokyo, Japan.
P7.86 CD4+ killer T cells are involved in the alopecia areata
A. Mukuno, H. Tsuboi, T. Fujimura, Y. Hamada and K. Katsuoka. Sagamihara and Yokohama, Japan.
P7.87 A controlled study of liquid nitrogen efficacy in treatment of alopecia areata involving less than 25% of the scalp
B. Matard, C. Jouanique, S. Abdennader, V. Saada, F. Nico, P. Assouly and P. Reygagne. Paris, France.
P7.88 Successful treatment of alopecia areata with imiquimod 5% cream
S. Hezel, T. Schmook, I. Nindl, N. Mandt, J. Rцwert, W. Sterry and E. Stockfleth. Berlin, Germany.
P7.150 The efficacy low dose cyclosporine a in patients with alopecia areata
A. Tarajkowska–Olejnik, M. Sіowiсska and L. Rudnicka. Warsaw, Poland.
Hair Disorders - Clinical Aspects
P8.89 The Kцbner phenomenon in trichology
R. d’Ovidio, J. Claudatus and T. Di Prima. Catania, Italy.
P8.90 A case of keratosis pilaris decalvans and acne keloidalis nuchae
A. H. Chong, Victoria, Australia.
P8.91 New hypothesis about common baldness
A. J. Soler. Alicante, Spain.
P8.92 Scarring alopecia – manifestation of different skin diseases
L. Oremoviж, I. Sjerobabski Masnec and L. Lugoviж. Zagreb, Croatia.
P8.93 A case of central trichoptilosis with nail dystrophy
Y. H. Nam, M. Im, Y. J. Seo, J. H. Lee and J. K. Park. Teajon, Korea.
P8.94 Red meat consumption in the UK has declined over the past 15 years with significant health consequences for the UK adult population potentially leading to more women and men developing chronic telogen effluvium
N. Frigй and D. H. Rushton. Portsmouth, UK.
P8.95 Diffuse non-scarring alopecia- a study of 3,500 cases
S. Murugusundram, S. Shivakumar and P. Yesudian. Chennai, India.
P8.96 Trichotillomania – an important cause of diffuse alopecia
S. Murugusundram, S. Shivakumar and P. Yesudian. Chennai, India.
P8.97 The question of whether low serum ferritin is associated with hair loss in women. With a related discussion as to whether other nutritional factors have any influence on hair shedding as evaluated in a survey of 2,147 women
R. Lurie. Petah Tiqva,Tel Aviv and Kupat-Holim Clalit, Israel.
P8.98 Nevoid basal cell carcinoma syndrome with multiple hair shaft defects
R. Lurie, D. M. Michael and E. Hodak. Petah Tivka, Israel.
P8.99 An unusual case of perifolliculitis abscedens et suffodiens
M. Ramos, R. Ferrusco and M. Rodriguez. Zapopan, Mexico.
P8.100 Generalized hypotrichosis with features of loose anagen hair syndrome- report of a family with autosomal dominant inheritance
S.-J. Lin, S.-H. Jee and H.-C. Chiu. Taipei, Taiwan.
P8.101 Alopecia areata associated with pityriasis lichenoides et varioliformis acuta and nevus flammeus
W. Chen, C.-C. Yang, S.-C. Chao and J. Y.-Y. Lee. Kaohsiung and Tainan, Taiwan.
P8.102 Patients with large prostate size show higher prevalence of androgenetic alopecia
C.-C. Yang, T.-S. Tzai, M.-C. Wu and W. Chen. Tainan and Kaohsiung, Taiwan.
P8.103 A clinical study of androgenetic alopecia (2002-2003)
J. E. Kim, J. Y. Ahn and B. I. Ro. Seoul, Korea.
P8.104 Primary cicatricial alopecias background
R. M. Ngwanya. Cape Town, South Africa.
P8.105 Autosomal dominant familial loose anagen hair syndrome associated with absence of vellus hair and generalized hypotrichosis - study of a family with 25 patients
S.-J. Lin, S.-H. Jee and H.-C. Chiu. Taipei, Taiwan.
P8.106 Postmenopausal frontal fibrosing alopecia
L. Tцrцk, Б. Kirscher and Sz. Nйmeth. Kecskemйt, Hungary.
P8.107 Nethertonґs disease in two siblings- a five-year follow up
N. Mandt, J. Vieten, K. Zappel, S. Blind and U. Blume-Peytavi. Berlin,
P8.108 Two cases of tufted folliculitis
N. O. Koch. Jalisco, Mexico.
P8.109 Mechanisms of endogenous skin aging
E. Makrantonaki, S. Fimmel, H. Seltmann and C. E. Orfanos, Ch.C. Zouboulis. Berlin, Germany.
P8.110 Estrogen activity on human skin involves interaction with the insulin-like growth factor-I (IGF-I) signalling pathway
E. Makrantonaki, M. Oeff, S. Fimmel, C. E. Orfanos and Ch. C. Zouboulis. Berlin, Germany.
P8.111 Microarray analysis of IGF-I and IGF- II regulated gene expression in human dermal papilla fibroblasts
J. J. Bull, Y. Liu, J. Monson, O. Djahanbakhch and M. P. Philpott. London, UK.
P8.112 Corticotropin-releasing hormone is involved in androgendependent skin disorders
Ch. C. Zouboulis, K. Orlowski, A. Schnitger, E. Glass, S. Fimmel, N. Hiroi, H. Seltmann, W. Chen, S. R. Bornstein. Berlin, Duesseldorf and Tainan, Germany and Taiwan.
P8.113 Cultured sebocytes: A model for studies on the regulation of steroid acute regulatory protein and cutaneous steroidogenesis
W. Chen, C.-C. Yang, H.-M. Sheu and Ch. C. Zouboulis. Kaohsiung, Tainan and Berlin, Taiwan and Germany.
P8.114 Control of androgen receptor expression in human skin cells and in a reconstituted human epidermis model with antisense ligonucleotides
S. Fimmel, F. Bontй, R. Kurfьrst and Ch. C. Zouboulis. Berlin and St. Jean de Braye, Germany and France.
P8.148 Cicatricial alopecia / lichen planopilaris- the Cleveland Clinic Foundation experience on evaluation, diagnosis and treatment
W. F. Bergfeld, B. K. Remzi and N. C. Cevasco. Cleveland and Toledo, USA.
P8.152 Global evaluation of hair loss in male androgenetic alopecia: European (EU) training and validation versus US experts
E. Sandraps, D. Herbaut, P. Lelubre, T. Leroy, D. Van Neste. Tournai, Belgium.
P8.153 The epidemiology of androgenetic alopecia
Rod Sinclair, Desmond Gan, Melbourne, Australia.
P8.154 Lack of significant decrease in total hair follicle number with advancing age
Rod Sinclair, Adam Chapman, Jill Magee, Melbourne, Australia.
Hair Diagnostics, Therapy
P9.115 Importance of serum ferritin levels in the diagnosis of chronic telogen effluvium
M. I. Rendon, G. R. Ciocca and J. I. Gaviria. Miami, USA.
P9.116 Optical coherent tomography (OCT): a new method for onlinemeasurement of hair shaft thickness
U. Blume-Peytavi. Berlin, Germany.
P9.117 Effectiveness of the association cetirizine – topical steroids in some cases of lichen planus-pilaris and pseudoarea of brocq - pilot study
R. d’Ovidio, J. Claudatus and T. Di Prima. Catania, Italy.
P9.118 Does aminexil prevent hair loss in patients with androgenetic alopecia who stop finasteride treatment?
C. Vincenzi, A. Rossi, C. Cantisani, M. Pazzaglia and A. Tosti. Bologna and Rome, Italy.
P9.119 Topical diphenylcypropenone (DPCP) for the treatment of extensive alopecia areata
G.-S. Choi, S.-K. Lee and J.-H. Shin. Incheon, Korea.
P9.120 Minoxidil 5% topical solution is effective in patients with previous treatment failure of finasteride or 17-alpha estradiol
K. Mulzer and J. Rundegren. Karlsruhe and Helsingborg, Germany and Sweden.
P9.121 Efficacy of minoxidil 5% topical solution in the treatment of androgenetic alopecia is not influenced by hair colour
K. Mulzer and J. Rundegren. Karlsruhe and Helsingborg, Germany and Sweden.
P9.122 Is it ethical to use placebo controls in male pattern hair loss studies when we have effective active controls?
D. H. Rushton and I. D. Ramsay. London, UK.
P9.123 A randomized trial of adenosine in androgenetic alopecia
Y. Watanabe, K. Nagashima, N. Hanzawa, M. Ogo, A. Ishino, Y. Nakazawa, M. Uemura, and M. Tajima. Yokohama and Tokyo, Japan.
P9.124 Bilateral double-lined scleroderma en coup de sabre treated with an oral vitamin D analogue
V. Verlinden, V. Meuleman, S. Segaert and H. Degreef. Leuven, Belgium.
P9.125 The effect of 1mg finasteride daily in treatment of androgenic alopecia in women
A. Tarajkowska-Olejnik and L. Rudnicka. Warsaw, Poland.
P9.126 Effects of the mixture of herbal medicine extracts on hair growth in C3H mice and patients with androgenetic alopecia
M. Tanaka, T. Yamaguchi, D. Matsuura, Z. Kawakami, S. Takeda, M. Aburada,S. Watanabe and S. Arase. Ibaraki, Tokyo and Tokushima, Japan.
P9.127 The herbal mixture xiantene had significant effects on hair growth in a preliminary double-blind, vehicle-controlled study in men with androgenic alopecia
P. G. Davies and V. A. Randall. Bradford, UK.
P9.128 Atrophic telogen effluvium’ from cytotoxic drugs and an investigation into a protective effect of pretreatment with a topical vitamin D3 analogue in man
T. O. Blieker, N. Nicolaou, J. Traulsen and P. E. Hutchinson. Leicester, UK.
P9.129 Novel and established potassium channel openers stimulate hair follicle growth in vitro and their effects are opposed by inhibitors: implications for their modes of action in hair follicles
G. C. Davies, M. Julie Thornton, T. J. Jenner, Y. C. Chen, J. B. Hansen, R. D. Carr and V. A. Randall. Bradford and Bagsvaerd, UK and Denmark.
P9.130 Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism
K. Kobayashi, N. Wakisaka, Y.-I Taira, M. Ishikawa, Y. Nakamizo, M. Uwabu, Y. Fukuda, Y. Taguchi, T. Hama and M. Kawakami. Tokyo, Japan.
P9.149 Authenticity of long curated historical hair samples - the case of Newton’s Hair
A. S. Wilson, M. P. Richards, M. Thomas and P. Gilbert. Bradford and Tucson, UK and USA.
Hair Care, Hair Surgery, Epilation
P10.131 In vitro fungicidal efficiency of ciclopiroxolamine alone and associated to pyrithione zinc against malassezia species
C. Roques, M. Jeanjean, V. Ermosilla, V. Sibaud and C. Panizzutti. Toulouse and Castanet Tolosan, France.
P10.132 Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, seba- ceous lipids, and individual sensitivity
Y. M. DeAngelis, M. O. Leland, T. Boekhout, J. R. Kaczvinsky, S. Whitaker, D. Keanneally, J. R. Schwartz and T. L. Dawson Jr.. Cincinnati and Utrecht, USA and The Netherlands.
P10.133 A retrospective assessment of response to treatment with 1% pyrithione zinc shampoo in african americans with moderate to severe dandruff/seborrheic dermatitis
W. L. Billhimer and M. A. Copas. Cincinnati, USA.
P10.134 GP4G stimulates human hair follicle cells metabolism and growth in organ culture
S. Lachgar, L. Fort-Lacoste, V. Ermosilla and M. Charvйron. Toulouse, France.
P10.135 An investigation of the impact of ZPT containing anti-dandruff shampoos on scalp irritation and itch associated with dandruff
K. M. Kerr, J. R. Schwartz, D. C. Kenneally and C. H. Margraf. Cincinnati, USA.
P10.136 The damage and restoration of integral hair lipid following treatment with hair dye
S. H. Chun, E. Lee , M. S. Song, T. H. Oh and W.-S. Lee. Wonju, Korea.
P10.137 The damage and restoration of hair lipid barrier following treatment with permanent hair waving
S. H. Chun, E. Lee , M. S. Song, and W.-S. Lee. Wonju, Korea.
P10.138 Amino acids - improving hair fibre properties in cosmetic hair problems
C. Gummer and S. Shiel. Egham, UK.
P10.139 Interest in gamma-cyclodextrin in the formula of a hair-loss lotion : evaluation by sensory metrology
I. Bacle, S. Meges, P. Lefranзois, J. J. Voisard, M. Luspot, S. Chesnoy, M. Delaunois and P. Morinet. Vigoulet, France.
P10.140 Exogenous hair damage: light microscopy of human hair shafts after in-vitro damage and application of hair care products
A. M. Finner, J. Welzel. Berlin and Luebeck, Germany.
P10.141 Effectiveness of serenoa repens on androgenetic alopecia
C. Fasulo, A. Linguiti, L. Bosco, P. Morranti and R. A. Satriano. Battipaglia and Naples, Italy.
P10.142 Molecular mechanism of the hair growth promoting effect by the combination of 6-benzylaminopurine and pentadecanoic acid
T. Midorikawa, T. Chikazawa, N. Sato, T. Yoshino and K. Takada. Odawawara, Japan.
P10.143 Follicular unit transplantation: the option of beard construction in eunuchoid man
K. Sahinoglu and S. Sonmez Ergьn. Istanbul, Turkey.
P10.144 Combined treatment with laser and topical eflornithine is more effective than laser treatment alone for removing unwanted facial hair – a placebo-controlled trial
E.Tan, I. Hamzavi, J. Shapiro and H. Lui. Vancouver, Canada.
P10.145 Evaluations of photo-epilation effect by gross observations are reliable?
C. Huh, J. Oh and K. Park. Kyounggi and Seoul, Korea.

Leave a Comment


Lost Password


The registration is limited to active EHRS Members only.

If you want to become EHRS Member, please fill out the application form.

If you already are EHRS Member, please, contact us to get registered.
Thank you.